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Purpose: FERM domain containing protein 7 (FRMD7) mutations are associated with X-linked idiopathic congenital
nystagmus (ICN). The purpose of this study is to identify a novel splice variant of FRMD7 (FRMD7-S) in both humans
and mice with a shortened exon 4 relative to the original form of FRMD7 (FRMD7-FL),and to detect the role of FRMD7-
FL and FRMD7-S in the process of neuronal development.
Methods: The splice variant of FRMD7 was identified by PCR. Expression levels of hFRMD7-FL and hFRMD7-S
transcripts in developing human  fetal  brain  were  tested  by  RT–PCR,  and  expression  levels  in  the  human pluripotent
embryonic  carcinoma  NTera  2/cl.D1  (NTERA-2;  NT2)  cell  line  with  all-trans  retinoic  acid  (ATRA)  or  bone
morphogenetic protein-2 (BMP-2) treatment were tested by real-time qPCR. hemaglutinin (HA)-tagged recombinant
plasmids DNA encoding hFRMD7-FL and Myc-tagged recombinant plasmids DNA encoding hFRMD7-S were used to
transiently transfect the human NT2 cells. Further, immunofluorescence experiments were performed to determine the
co-localization of the two fusion proteins. Finally, using co-immunoprecipitation analyses, we demonstrated that FRMD7-
FL and FRMD7-S interacted with each other.
Results: A novel splice variant of FRMD7 (FRMD7-S) with a shortened exon 4 relative to the original form of FRMD7
(FRMD7-FL) was identified from the cDNA of the human NT2 cell line and mouse fetal brain. The FRMD7 transcripts
showed similar tissue distributions and were upregulated following all trans retinoic acid (ATRA)-induced differentiation
of  NT2  cells.  FRMD7-FL  and  FRMD7-S  co-localized  and  co-immunoprecipitated  with  each  other.  Further,
overexpression of FRMD7-FL in NT2 cells resulted in altered neurite development and upregulation of FRMD7-S.
Conclusions: Although the significance of the 45 bp deletion remains unknown, our observations suggest that the
FRMD7 isoforms may play a significant role during neuronal differentiation and development.
Idiopathic congenital nystagmus (ICN) is an oculomotor
disorder characterized by involuntary horizontal oscillations
of the eyes that presents at birth or appears in the first months
of life, but does not usually worsen over time. ICN is distinct
from other ocular disorders in which nystagmus is acquired
later  in  life  (e.g.,  cataracts,  glaucoma,  albinism)  or  is
accompanied by eye, brain, or other health abnormalities [1].
The prevalence of ICN is estimated to be 24 per 10,000 [2],
and  although  some  techniques  can  improve  vision  (e.g.,
glasses, contact lenses, eye muscle surgery), nystagmus is
usually permanent and cannot be corrected or cured [3].
Previous studies have speculated that ICN represents a
primary defect in the brain regions involved in ocular motor
control  [4],  although  the  precise  pathogenic  mechanisms
underlying  ICN  are  currently  unknown.  Mutations  in  the
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human FERM domain containing protein 7 (FRMD7) gene
(NM_194277), which encodes the FERM domain containing
protein 7 that is a member of the FERM family, are associated
with  X-linked  ICN  [5].  Approximately  50%  of  X-linked
pedigrees and 5% of sporadic ICN cases have been linked to
FRMD7 mutations, and more than 35 FRMD7 mutations have
been reported worldwide in families with X-linked ICN from
various ethnic backgrounds [1,6,7].
The  298  amino  acid  FERM  domain  was  originally
identified in protein 4.1 [8], and subsequent studies reported
the structural, transport, and membrane-localizing functions
of this domain [9-11]. Notably, the hFRMD7-FL protein is
highly  homologous  to  FARP1  (FERM,  RhoGEF,  and
pleckstrin domain protein 1) and FARP2 proteins, which are
known  to  play  significant  roles  in  neuronal  development.
FARP1 is necessary and sufficient for promoting lateral motor
column  dendritic  growth,  and  FARP2  is  a  key  molecule
involved in the response of neuronal growth cones to class-3
semaphorins  [12,13].  Moreover,  recent  studies  have
demonstrated that inhibition of FRMD7 expression in mouse
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2987neuroblastoma  cell  line  (NEURO2A)  during  neuronal
differentiation is associated with significant delays in neurite
growth  and  disrupted  F-actin/G-actin  dynamics  [14].  In  a
mouse model, FRMD7 expression levels were low in all adult
tissue  samples,  whereas  FRMD7  expression  levels  were
higher  in  embryos  and  underwent  a  sharp  increase  at
embryonic day 18 in brain tissue [15]. These findings provide
evidence that FRMD7 plays a critical role during neuronal
morphogenesis, in synapse function, and in neurite growth,
but further studies will be required to uncover the precise
mechanisms associated with FRMD7 function.
The  NT2  cell  line,  which  is  a  human  embryonic
carcinoma cell line, differentiates into post-mitotic neuron-
like  cells  following  treatment  with  all  trans  retinoic  acid
(ATRA) [16,17] and into non-neural epithelial cell lineages
following exposure to bone morphogenetic protein 2 (BMP-2)
[18,19]. Therefore, NT2 cells provide an ideal model system
that  mimics  normal  neuronal  differentiation  in  the  brain
according to many established criteria.
Previous studies have revealed that alternative splicing
occurs much more frequently in the brain relative to other
tissues  [20,21],  and  alternative  splicing  is  increasingly
recognized for its role in neurologic disease [22,23]. In the
current study, we have identified and characterized a novel
FRMD7  splice  variant  in  humans  and  mice,  hFRMD7-S
(GenBank  FJ717411)  and  mFRMD7-S,  respectively;  the
splice variant contains a 45 bp truncation in the fourth exon
and produces an altered form of the FERM domain. Herein,
we  investigate  the  expression  patterns,  role  in  neurite
development,  subcellular  localization,  and  interactions
associated with the FRMD7-S splice variant relative to the
original FRMD7-FL isoform in NT2 cells.
METHODS
Cell  culture  and  ATRA/BMP-2-induced  differentiation:
Human  NT2  cells  (Cell  Culture  Center  of  Peking  Union
Medical College, Peking, China) were maintained in DMEM/
F12 medium supplemented with 10% fetal bovine serum, 100
U/ml penicillin, and 100 μg/ml streptomycin. Prior to the
induction of differentiation, the NT2 cells were incubated in
25 cm2 cell culture flasks in 4 ml of medium in a 37 °C, high
humidity, 5% CO2 incubator. The cells were trypsinized and
sub-cultured at a ratio of 1:3 twice weekly. For the time course
analyses, the NT2 cells were seeded on a 3.0×106/10 cm2 plate
and treated the following day with 10 μM all-trans retinoic
acid (ATRA) dissolved in DMSO [16,17] or with 50 ng/ml
bone morphogenetic protein-2 (BMP-2) dissolved in normal
saline [18,19]. The cells were collected at 12, 24, 36, 48, and
72 h after treatment for the early time points. For the later time
points (5, 8, and 12 days), the cells were reseeded every three
days  in  the  continued  presence  of  ATRA  or  BMP-2  and
collected on the corresponding days.
Collection of human and mouse fetal tissue: Freshly isolated
16-week post-conception (wpc) aborted human fetal tissues
were  collected  from  the  Women's  Hospital  School  Of
Medicine Zhejiang University. The experimental procedures
were  approved  by  the  Human  Ethical  Committee  of  the
Zhejiang University. Mouse fetal brain tissue was isolated
from 18-day mouse fetuses. A scissors was used to produce
1–3 mm3 pieces of tissue, which were snap frozen in cryogenic
vials in liquid nitrogen and stored at −80 °C. Total RNA from
each  sample  was  prepared  for  subsequent  RT–PCR
experiments.
RNA isolation, reverse transcription PCR, and quantitative
real-time PCR analysis: Total RNA was isolated from human
and mouse fetal tissues and NT2 cells using TRIZOL reagent
(Invitrogen, San Diego, CA), according to the manufacturer’s
instructions. Real-time quantitative PCR (RT-qPCR) assays
were  performed  using  a  Light  CyclerTM  real-time  PCR
thermocycler (Roche, Shanghai, China). Briefly, 1.5 μg of
total RNA was reverse transcribed using oligo (dT) 12–18
with M-MLV Reverse Transcriptase (Promega, Madison, WI)
according to the manufacturer's instructions. Relative levels
of gene expression were analyzed using the SYBR® Premix
Ex Taq™ (TaKaRa, Dalian, China) using the recommended
PCR conditions. The sequences of the RT-qPCR primers are
shown in Table 1. The relative mRNA levels of target genes
were  calculated  relative  to  glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) using the (=2-△△C
T) method [24].
cDNA clone and plasmid construction: Human FRMD7-FL
and FRMD7-S genes were isolated from NT2 cell cDNA
(synthesized from the total RNA of natural NT2 cells) by PCR
amplification using the following primers: 5′-ATG CTA CAT
TTA AAA GTG CAG TTT-3′ and 5′-TTA AGC TAA AAA
GTA  ATT  ACA  TGG  T-3′.  The  mouse  FRMD7-FL  and
FRMD7-S genes were cloned from 18-day fetal mouse brain
cDNA using the following primers: 5′-GTA TGG ATC CAT
GCT CCA TTT AAA AGT G-3′ and 5′-AGC TAA GAA ATA
ATT GCA TGG CTT TAG C-3′. PCR was performed in
25 μl of a reaction mixture containing DNA polymerase from
Thermococcus  kodakaraensis  (KOD)  DNA  polymerase
buffer and 1.25 U KOD DNA polymerase (Toyobo, Osaka,
Japan). Subsequent cloning of PCR products into the pEASY-
Blunt  vector  (TransGen  Biotech,  Beijing,  China)  was
performed  using  the  pEASY-Blunt  Cloning  Kit  for
Sequencing  (TransGen  Biotech).  Sequence  analyses  were
performed by the Invitrogen Company (Shanghai, China). To
generate eukaryotic expression vectors for hFRMD7 splice
variants, cloned RT–PCR fragments in pEASY-Blunt were
used as the template. The hFRMD7-FL cDNA was sub-cloned
into pcDNA3.1(+) in frame with an NH2-terminal HA tag
(hFRMD7-FL-HA) and pEGFP-N1 (pEGFP-hFRMD7-FL)
with the pAf/pAr and pCf/pCr primer sets, respectively (Table
1). The hFRMD7-S gene was subcloned into pcDNA3.1(+)
with  an  NH2-terminal  Myc  tag  (hFRMD7-S-Myc)  and
plasmid pDsRed-N1 (pDsRed-hFRMD7-S) using the pBf/
pBr and pDf/pDr primer sets, respectively (Table 1). NheI and
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2988XhoI were chosen as the cloning sites for all three vectors, and
the sequences of all of the expression cassettes were verified.
Cell transfection and immunofluorescence microscopy: For
transient transfection experiments, the NT2 cells were placed
on glass coverslips or cell culture flasks until they reached
approximately 60% confluency and were transfected with
FuGENE HD transfection reagent (Roche) at a ratio of 1 μg
of DNA to 3 μl of FuGENE HD per coverslip. The cells were
processed for immunofluorescence at 48 h post-transfection.
For  stable  overexpression  experiments,  G418  (1.2  μg/  ml
medium; Invitrogen) antibiotic selection was performed for 4
weeks. For the immunofluorescence experiments, the induced
or  transfected  NT2  cells  were  washed  with  phosphate-
buffered  saline  (PBS)  and  fixed  for  15  min  at  room
temperature  in  4%  paraformaldehyde  (PFA)  in  PBS.  The
coverslips were washed twice with ice-cold PBS, and the cells
were permeabilized with PBS containing 0.2% Triton X-100
for 10 min at 4 °C. After washing the cells in PBS three times
for 5 min (each wash), a blocking solution containing PBS and
10%  normal  goat  serum  was  applied  for  1  h  at  room
temperature.  Afterwards,  primary  antibodies  (monoclonal
anti-Myc or anti-HA or antibodies; Abmart Inc., Shanghai,
China) diluted in a blocking solution were applied overnight
at 4 °C or for 1 h at room temperature. In the double-labeling
Figure 1. Cloning of a novel FRMD7 isoform and tissue distribution of the two splice variants. A: Components of the FERM domain and gene
structure of hFRMD7-FL. B and C: Sequence comparison between hFRMD7-FL/mFRMD7-FL (B) and hFRMD7-S/mFRMD7-S (C) showing
the deletion of 45 bp in the 5′ end of exon 4 in the hFRMD7-S/mFRMD7-S. D: Agarose gel electrophoresis of the RT–PCR products to confirm
their size and the identification of a single PCR product. E: Expression levels of hFRMD7-FL and hFRMD7-S transcripts in selected human
fetal tissues. The primer sets used in D and E: p1f/p1r, p2f/p2r and p3f/p3r.
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2989experiments, the cultures were incubated simultaneously with
two  primary  antibodies.  After  three  washes  in  PBS,  the
secondary  antibodies  (Dylight  488,  Dylight  594;  Jackson
ImmunoResearch Laboratories, Inc. West Grove, PA) were
diluted 1:250 in a blocking solution and added for 1 h at room
temperature in the dark. The secondary antibody solution was
decanted and washed three times with PBS for 5 min each in
the dark. Finally, the cells were incubated for 5 min with
0.1 μg/ml DAPI as a nuclear counterstain. After three washes,
the  coverslips  were  mounted  with  a  drop  of  Antifade
Mounting  Medium  (Beyotime  Institute  of  Biotechnology,
Suzhou, China) and stored in the dark at −20 °C or 4 °C. The
cells were viewed using a Nikon eclipse inverted fluorescence
microscope equipped with a Nikon digital camera (Nikon
Corporation,  Tokyo,  Japan).  Image  overlays  and  contrast
enhancement were performed using Adobe Photoshop CS2
(Adobe Systems Inc. San Jose, CA) software.
Co-immunoprecipitation and immunoblot analyses: For co-
immunoprecipitation  (co-IP)  experiments,  NT2  cells  were
transiently co-transfected with 2 μg of each of the hFRMD7-
FL-HA  and  hFRMD7-S-Myc  vectors.  At  48  h  post-
transfection, the total protein been extracted from the cells by
using  M-PER®  Mammalian  Protein  Extraction  Reagent
(Thermo Fisher Scientific Inc., Rockford, IL) following the
manufacturer's  instructions.  Then  the  ProFound™  Co-
Immunoprecipitation Kit (Thermo Fisher Scientific Inc.) was
used  for  co-IP  assays  according  to  the  manufacturer's
instructions. Control immunoprecipitations were performed
in the presence of non-specific immunoglobulins.
Statistical analyses: All experiments were done in triplicate,
and  the  data  are  represented  as  mean±SEM.  Statistical
significance  between  groups  was  determined  using  the
Kolmogorov–Smirnov  test  and  Student’s  t-test,  as
implemented by SPSS13.0 (SPSS Inc., Chicago, IL). Results
were considered to be statistically significant when p<0.05.
RESULTS
Identification of a novel FRMD7 splice variant and tissue
distribution  of  two  FRMD7  transcripts:  In  RT–PCR
experiments to clone the hFRMD7-FL gene from NT2 cells,
two  PCR  products  were  produced.  Cloning  and  sequence
analysis of the PCR products indicated that they corresponded
to  two  distinct  FRMD7  mRNAs:  the  expected  original
hFRMD7-FL  mRNA  and  another  unexpected  mRNA  not
described previously, which is referred to herein as hFRMD7-
S. This novel transcript, which lacks a 45 bp segment in the 5′
region of exon 4, results in the fusion of the 3′ end of exon 3
to  the  5′  end  of  truncated  exon  4;  therefore,  hFRMD7-S
encodes a putative protein of 699 amino acids (Figure 1A,B).
We  then  performed  RT–PCR  to  confirm  the  presence  of
mFRMD7-S  in  18-day-old  fetal  mice  (Figure  1C).  The
expression of hFRMD7-FL and hFRMD7-S transcripts was
examined in tissues from 16-wpc human fetal tissue using
sequence-specific  primers  (Figure  1D).  We  detected  high
expression of hFRMD7-FL in the cerebellum and moderate
expression in the cerebral cortex, optic nerve, kidney, testis,
and gastric wall. We detected high expression of hFRMD7-S
in the cerebellum and moderate expression in the kidney,
testis,  and  gastric  wall.  However,  hFRMD7-S  was  not
Figure  2.  Effects  of  ATRA/BMP-2
induction on the expression of FRMD7
splice variants in NT2 cells. A and B:
NT2 cells were treated with ATRA (10
µM) or vehicle (0.1% DMSO) for the
indicated periods. C and D: NT2 cells
were treated with BMP-2 (50 ng/ml) or
vehicle (normal saline) for the indicated
time  periods.  Expression  levels  of
hFRMD7-FL  and  hFRMD7-S
transcripts  were  determined  by  RT-
qPCR. The vehicle-treated cells did not
show any significant change (data not
shown). The primer sets were used for
RT-qPCR: p1f/p1r, p2f/p2r and p3f/p3r.
Both the transcript levels are normalized
to GAPDH mRNA levels. The data are
presented as fold changes relative to 0 h.
The experiments were done in triplicate,
and the graphs represent the average of
three  independent  experiments
(Columns,  mean;  bars,  S.E.M.;
*p<0.05, **p<0.01 versus 0 h).
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2990expressed  in  the  optic  nerve  or  cerebral  cortex.  Neither
hFRMD7-FL nor hFRMD7-S were expressed in the medulla
oblongata,  pons,  or  liver.  Taken  together,  these  results
revealed that hFRMD7-S exhibited a similar but limited tissue
distribution compared to hFRMD7-FL (Figure 1E).
Levels of both hFRMD7 transcripts significantly increased in
ATRA-induced differentiating NT2 cells: As shown in Figure
2A,B,  the  levels  of  hFRMD7-FL  and  hFRMD7-S  mRNA
expression in NT2 cells started to increase at 12 h after ATRA
treatment and reached a maximal increase at 8 days (81 fold
Figure 3. Effects of hFRMD7-FL or hFRMD7-S overexpression on neurite outgrowth. NT2 cells stably transfected with hFRMD7-FL-HA
(A), hFRMD7-S-Myc (B), or the empty pcDNA3.1(+) vector (C) were treated with ATRA for 5 days. The cells were fixed and immunostained
with monoclonal anti-Myc or anti-HA antibodies and a DyLight-488 conjugated secondary antibody. Class III β-tubulin was immunostained
using a monoclonal TuJ1 antibody and DyLight-594 secondary antibody. Magnification: 200×.
TABLE 2. NEURITE OUTGROWTH OF NT2 CELLS TREATED WITH 10 μM RETINOIC ACID.
Norm Control hFRMD7-S hFRMD7-FL
Percentage of cells with neurites* 46.2±2.1 47.5±1.3 (ns) 77.8±1.6
Average neurite length** (μm) 42.7±2.6 43.6±2.1 (ns) 72.3±1.1
        Cells were treated with 10 μm retinoic acid, 10% FCS/DMEM-F12 for 5 days, and neurite parameters were quantified. Data are
        mean±SEM of three independent experiments. At least 250 cells per transfection were counted. *Cells that possess at least one
        outgrowth of more than one-half the cell body diameter in length. **Neurite length from cell body to distal tip. (ns) stands for
        Not Significant.
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2991for hFRMD7-FL and 96 fold for hFRMD7-S relative to the 0
h time point; Figure 2A,B). The control group did not exhibit
any change relative to the 0 h time point. Compared to ATRA,
BMP-2 had a repressive effect on hFRMD7-FL and hFRMD7-
S expression. After 24 h of BMP-2 treatment, the levels of
hFRMD7-FL and hFRMD7-S transcripts started to decline
relative to the 0 h time point, and continued to decrease after
36 h; after 8 days, the expression levels of hFRMD7-FL and
hFRMD7-S transcripts began to increase (Figure 2C,D).
hFRMD7-FL and hFRMD7-S co-localized with class III β-
tubulin  and  exhibited  differential  effects  on  neurite
development: Stable NT2 cell lines overexpressing hFRMD7-
FL-HA  or  hFRMD7-S-Myc  were  established  for  use  in
experiments to study their role during differentiation. We
examined the co-localization of class III β-tubulin, which is
not expressed at detectable levels in neural progenitor cells,
with  the  two  FRMD7  isoforms  by  indirect
immunofluorescence.  Both  isoforms  exhibited  strong  co-
localization with neuronal class III β-tubulin in differentiating
NT2 cells induced with ATRA for 5 days (Figure 3A,B).
Having  established  that  the  hFRMD7-FL  or  hFRMD7-S
overexpressed cell lines, we next sought to find how this
change would affect neurite development in differentiated
NT2 cells. Notably, following ATRA treatment for 5 days, a
Figure 4. Sub-cellular co-localization and co-immunoprecipitation of hFRMD7-FL with hFRMD7-S. Co-transfection of pEGFP-hFRMD7-
FL (green) and pDsRed-hFRMD7-S (red) into RA-untreated (A) or differentiating NT2 cells (B). After 48 h, the cells were fixed and DAPI
was used as a nuclear counterstain (blue). Magnification 400×. C and D: Reciprocal co-immunoprecipitation experiments show that hFRMD7-
FL-HA co-immunoprecipitates with hFRMD7-S-Myc, and vice versa, in NT2 cells. Cells transfected with only hFRMD7-S-Myc or hFRMD7-
FL-HA served as the negative control.
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2992significant increase in the length and number of neurites was
observed in NT2 cells stably overexpressing hFRMD7-FL-
HA NT2 (Figure 3A,C and Table 2; p<0.05). However, the
degree of neurite branching did not differ between the control
and hFRMD7-S overexpressing NT2 cells (Figure 3B,C and
Table 2; p>0.05).
hFRMD7-FL co-localizes and interacts with hFRMD7-S in
NT2 cells: To investigate the subcellular co-localization of
FRMD7 isoforms and to differentiate between the localization
of endogenous FRMD7 and exogenously expressed FRMD7
proteins, we used expression vectors to express hFRMD7-FL
or hFRMD7-S differentially tagged with green (EGFP) or red
(DsRed) fluorescent protein, respectively. Following transient
co-transfection with the fusion constructs encoding pEGFP-
hFRMD7-FL and pDsRed-hFRMD7-S, untreated NT2 cells
(without ATRA) and NT2 cells treated with ATRA for 7 days
were  subjected  to  fluorescence  microscopy.  In  these
experiments,  EGFP-hFRMD7-FL  and  DsRed-hFRMD7-S
exhibited a high degree of co-localization (Figure 4); both
isoforms  were  primarily  localized  in  cytoplasm  and
perinuclear regions in undifferentiated NT2 cells (Figure 4A).
Similarly, in NT2 cells induced with ATRA for 7 days, EGFP-
hFRMD7-FL  and  DsRed-hFRMD7-S  co-localized
extensively in the cytoplasm, perinuclear regions, and neurite
processes. Notably, the distribution of EGFP-hFRMD7-FL
was more abundant in the distal terminals of the neurites
relative to that of DsRed-hFRMD7-S (Figure 4B).
To test for protein–protein interactions, we performed co-
IP  experiments.  We  co-expressed  HA  and  Myc  NH2-
terminally tagged versions of hFRMD7-FL (hFRMD7-FL-
HA)  and  hFRMD7-S  (hFRMD7-S-Myc),  respectively,  in
NT2 cells. At 48 h post-transfection, total cell lysates were
extracted,  and  hFRMD7-FL-HA  was  immunoprecipitated
using anti-HA antibodies, followed by immunoblot analysis
with anti-Myc antibodies. The results showed that hFRMD7-
FL-HA  co-immunoprecipitated  with  hFRMD7-S-Myc
(Figure  4C).  This  finding  was  confirmed  by  reciprocal
immunoprecipitation  experiments,  which  showed  that
hFRMD7-S-Myc co-immunoprecipitated with hFRMD7-FL-
HA (Figure 4D). The results of these experiments may suggest
that hFRMD7-FL and hFRMD7-S either interact directly or
are associated with the same protein complex in NT2 cells.
hFRMD7-FL protein stimulates transcription of hFRMD7-S:
Alternative  splicing  often  impacts  the  transcription  and
subsequent translation of the major protein. Therefore, we
performed experiments to determine whether overexpression
of one FRMD7 splice variant was associated with altered
transcription of the other splice variant. Overexpression of
hFRMD7-FL or hFRMD7-S was confirmed by RT–PCR and
immunoblot analyses (data not shown). We found that the
transcription levels of hFRMD7-S exhibited a time-dependent
increase  in  cells  overexpressing  hFRMD7-FL  relative  to
control cells, with an average of 4.8 fold higher hFRMD7-S
expression levels at 72 h (Figure 5A); in contrast, hFRMD7-
FL transcription levels did not change significantly in NT2
cells overexpressing hFRMD7-S (Figure 5B).
DISCUSSION
The human FRMD7 gene spans a region of 2,145 bp and
comprises 12 exons. Until now, no FRMD7 mRNA variants
have been described. Herein, we report the discovery of a
novel transcript, hFRMD7-S, from the human FRMD7 gene
generated by alternative splicing. An increased understanding
of the hFRMD7-S variant relative to the original hFRMD7-
Figure 5. Overexpression of hFRMD7-
FL stimulates hFRMD7-S transcription.
Expression  levels  of  hFRMD7-FL  or
hFRMD7-S transcripts were monitored
by RT-qPCR in transfected NT2 cells at
the  indicated  time  points.  Cells
transfected with the empty vector served
as the negative control (MOCK group).
A: Expression levels of hFRMD7-S in
NT2  cells  overexpressing  hFRMD7-
FL. B: Expression levels of hFRMD7-
FL  in  NT2  cells  overexpressing
hFRMD7-S. The primer sets were used
for RT-qPCR: p1f/p1r, p2f/p2r and p3f/
p3r.  Both  the  transcript  levels  are
normalized to GAPDH mRNA levels.
The  data  are  presented  as  the  fold
changes relative to MOCK group. All of
the experiments were done in triplicate,
and  the  graph  represents  the  average
(columns, mean; bars, S.E.M.; *p<0.05,
**p<0.01 versus MOCK group).
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2993FL  transcript  may  help  clarify  the  role  of  FRMD7  splice
variants in neuronal development and the pathogenesis of
ICN.
We  found  that  the  hFRMD7-FL  and  hFRMD7-S
transcripts exhibit a similar tissue distribution, with highest
levels in the cerebellum; neither hFRMD7-FL nor hFRMD7-
S were expressed in the medulla oblongata or pons. These
results corroborate previous studies in mouse models [15].
Further, our previous studies demonstrated that hFRMD7-
FL expression is ubiquitous during fetal brain development,
but is restricted to regions of eye movement in adults [25]. We
may  suppose  that  the  FRMD7  transcripts  may  carry  out
cerebellum-associated  functions  (e.g.,  vestibulo-cerebellar
system regulation of normal eye movement). Nevertheless, in
the  previous  work,  using  immunohistochemistry  testing,
FRMD7-FL was observed to be highly expressed in the pons
and  medulla  oblongata.  Since  the  size  differences  in  the
corresponding mRNAs and protein isoforms are very small
(i.e., 2,145 bp for hFRMD7-FL versus 2,100 bp for hFRMD7-
S),  neither  northern  blot  nor  immunoblot  analyses  were
performed  to  determine  endogenous  hFRMD7-FL  and
hFRMD7-S protein expression. The reason for the differences
of expression distribution between RNA level and protein
level of FRMD7-FL are worth exploring in future studies.
Recent  studies  suggest  that  ATRA-induced
differentiation is followed by the upregulation of hFRMD7-
FL mRNA and protein expression levels in NEURO2A cells
[14].  In  the  current  study,  we  found  that  ATRA-induced
neuronal  differentiation  of  NT2  cells  resulted  in  elevated
expression of both hFRMD7-FL and hFRMD7-S transcripts,
whereas BMP-2 treatment of NT2 cells had a repressive effect
on hFRMD7-FL and hFRMD7-S expression. Further, a recent
study demonstrated that downregulation of hFRMD7-FL in
NEURO2A  cells  resulted  in  altered  neurite  development
[14].  In  the  current  study,  we  found  that  hFRMD7-FL
overexpression leads to a significant increase in neurite length
in  differentiating  NT2  cells;  however,  hFRMD7-S
overexpression had no effect on this process.
NT2 cells undergo programmed terminal differentiation
along a neuronal pathway, resulting in the accumulation of
neuronal  cells  with  neurite  outgrowths  and  extended
processes within a period of 8 days. Thus, we speculate that
both hFRMD7-FL and hFRMD7-S are involved in the process
of  neurite  outgrowth  extension.  Since  hFRMD7-FL  and
hFRMD7-S share highly similar sequences, their different
effect on ATRA-induced NT2 differentiation is of particular
interest.  Although  it  is  unclear  what  underlies  these
differences, our findings suggest that the FRMD7 isoforms are
involved  in  the  formation  and  growth  of  neurites  during
neuronal differentiation, and also provide evidence that the
hFRMD7-S isoform may play a minor role during this process.
A previous study showed that FARP1 and FARP2, which
share  homology  with  FRMD7,  are  involved  in  signal
transduction between the plasma membrane and cytoskeleton,
and that the hFRMD7-FL protein co-localizes with actin in
NEURO2A cells [12-14,26,27]. In the current study, we found
that hFRMD7-FL and hFRMD7-S splice variants also exhibit
strong  co-localization  with  class  III  β-tubulin,  which  is
considered  to  be  one  of  the  earliest  neuron-associated
cytoskeletal marker proteins during mammalian development
[28,29]. These results give evidence that the FRMD7 isoforms
carry  out  functions  associated  with  microtubules  and
cytoskeleton-associated proteins or at least play a role in a
related molecular pathway.
We found that the hFRMD7-FL isoform co-localized to
a high extent with the hFRMD7-S isoform in undifferentiated
and  differentiating  NT2  cells,  although  the  hFRMD7-FL
isoform exhibited a more abundant distribution in the distal
terminals  of  axon  branches  relative  to  the  hFRMD7-S
isoform. These differences may be due to different levels of
protein  translation  efficiency.  Further,  the  results  of  our
reciprocal co-IP experiments also suggest that hFRMD7-FL
and hFRMD7-S interact in NT2 cells. Taken together, these
results uncovered a putative protein complex formed by the
two  FRMD7  isoforms;  however,  further  studies  will  be
required to confirm this finding.
Notably, we also found that hFRMD7-FL overexpression
led to the stimulation of hFRMD7-S gene expression in NT2
cells,  whereas  overexpression  of  hFRMD7-S  showed  no
significant effect on hFRMD7-FL expression. These results
indicate that hFRMD7-FL might be involved in hFRMD7-S
regulation.  Considering  their  different  effects  on  ATRA-
induced NT2 differentiation, we speculate that hFRMD7-S
plays a less important role of biologic functions. Although the
mechanism(s)  by  which FRMD7-FL  regulates  hFRMD7-S
expression  remains  elusive,  we  speculate  that  the  altered
FERM domain in hFRMD7-S may explain its inability to
regulate hFRMD7-FL expression.
In  conclusion,  we  identified  a  novel  FRMD7  variant
generated by alternative mRNA splicing that results in the
deletion of 45 base pairs in exon 4. This is the first splice
variant of FRMD7 to be reported. The two isoforms share a
similar tissue distribution, and they co-localize and interact
with  each  other  in  NT2  cells.  However,  the  hFRMD7-S
isoform showed a slightly limited tissue distribution and a
limited function in altering the length and number of neurites
in  differentiating  NT2  cells  relative  to  the  hFRMD7-FL
isoform. Taken together, although the significance of the 45
bp deletion remains unknown, our observations suggest that
the  FRMD7  isoforms  may  play  a  significant  role  during
neuronal  differentiation  and  development.  Therefore,
although additional studies will be required to further confirm
the  association  between  the  two  transcripts,  the  current
findings  may  enhance  our  understanding  of  their  precise
functional roles in the pathogenesis of ICN.
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